Jun Gong, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Exelixis
    Topic:
    HCC
    Date added:
    05/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    09/22/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Elsevier
    Topic:
    Renal cell carcinoma
    Date added:
    05/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bayer
    Topic:
    Colorectal Cancer
    Date added:
    05/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    05/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Incyte
    Topic:
    Cholangiocarcinoma
    Date added:
    05/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    10/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eisai
    Topic:
    HCC
    Date added:
    05/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    01/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seagen
    Topic:
    Colorectal Cancer
    Date added:
    05/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    02/03/2023
Return to BTF's 2024 Updates on Hematology and Oncology, Fresno